47783-644 : Takhzyro 300 mg/2ml Subcutaneous Injection, Solution
NDC: | 47783-644 |
Labeler: | Dyax Corp. |
Product Type: | Human Prescription Drug |
Drug Name: | Takhzyro |
Dosage Form: | Subcutaneous Injection, Solution |
Application #: | BLA761090 |
Rev. Date: |
NDC Package Codes:
- 47783-644-01: 1 VIAL, GLASS IN 1 CARTON (47783‑644‑01) > 5 ML IN 1 VIAL, GLASS
Active Ingredients:
- Lanadelumab
Dosage Strength:
- 300 mg/2mL
Pharmaceutical Classes:
- Kallikrein Inhibitors [MoA]
- Plasma Kallikrein Inhibitor [EPC]
Related Products:
Based on records with the same trade name.- 47783-645 Takhzyro 150 mg/ml Subcutaneous Solution by Takeda Pharmaceuticals America, Inc.
- 47783-646 Takhzyro 300 mg/2ml Subcutaneous Solution by Takeda Pharmaceuticals America, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 47783-101Next: 47783-645 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.